Working to Eradicate Gynecologic Cancers

Mike Sill, PhD

Statistician
Gynecologic Oncology Group Statistical and Data Center
Roswell Park Cancer Center
Elm and Canton St
Buffalo, NY
USA 14263

Papers:
24 Impact of circulating tumor cells (CTCs) on overall survival among patients treated with chemotherapy plus bevacizumab for advanced cervical cancer: an NRG Oncology/Gynecologic Oncology Group study 53 A phase II trial of trebaninib (AMG 386), a selective angiopoietin 1/2 neuralizing peptibody in patients with persistent/recurrent carcinoma of the endometrium: a Gynecologic Oncology Group study A Phase II Evaluation of Cediranib in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study